Scientific Innovation is at the Core of Everything We Do #
We are pioneers in neuroregenerative medicine. Our functional neurogenesis stimulation technology focuses on enhancing the natural process of nerve cell repair to restore function and relieve symptoms for people with neurological conditions. Our protocols are the product of cutting-edge medical science designed to help the body regrow damaged neural tissue, the circuitry that powers the brain.
The Challenge of Healing Neural Tissue #
The nervous system includes your brain, spinal cord, and peripheral nerves – a network of nerves that connect your brain and spine to the rest of your body.
Neuroregeneration is the process of healing neural tissue, the tissue that makes up the nervous system, after an injury. When the peripheral nerves are injured, your body has ways to fix the damage and restore the function of its cells.
But your brain doesn’t have these same tools, and research shows that it may even have factors that stop neuroregeneration. The brain’s inability to fix damage on its own is one of the reasons why brain injuries are often so serious and disabling.
A major focus in modern-day neuroscience is finding ways to encourage neuroregeneration in the brain.
We’re at the forefront of neuroregeneration research. #
Our focus is on helping the brain restore broken connections called neural tracts that connect different areas of the body. Our non-invasive protocols are designed to help stimulate brain cell regrowth and repair broken connections in the neural network.
These protocols include precisely calculated doses of electromagnetic signals, delivered in pulses to damaged cells. Using low-energy radiofrequency, we target signals directly at the cells. Functional neurogenesis stimulation is the promotion of new functional neural pathways.
Learn about our research and technology
We have studied our approach to neural tissue regeneration in a rigorous clinical trial on cerebral palsy and a series of open-label case studies on participants with other neurological conditions. Based on data from the clinical trial, COFEPRIS has approved our protocol to help relieve symptoms for children with cerebral palsy. We are also encouraged by some of our case studies in people with autism, stroke, traumatic brain injury, vascular dementia, and the neurological impacts of COVID-19. We have plans to conduct formal clinical trials on these conditions.
Our work on neurological disorders
Clinical Trial Findings in Cerebral Palsy (CP) #
Evidence from our clinical trials of participants' improvements is supported by structural and functional imaging data, including advanced functional MRI scans and brain mapping that provide detailed images of the brain and its neural connections. By comparing brain scans taken before and after participants received the protocol, we identified newly formed neural tracts—pathways that link different brain regions—and observed a correlation with symptom improvements in children with cerebral palsy.
Our clinical trial data suggests many more functional neurons are present after the protocol, particularly in areas where the brain was previously damaged. The results suggest the protocol has immense potential for healing neural tissue.
NeuroCytonix Mexico Clinical Research Center #
Discover the future of medical research at our state-of-the-art clinical research center.
